The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Even light-intensity activities such as walking can reduce one’s risk for clinical depression. So, what are the most common ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Inauguration Day in photos, the allure of coffee shops, how to handle seasonal depression: Catch up on the day’s stories ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Discover 7 strategies to combat depression, from spiritual practices to physical wellness, shared through one person's inspiring journey to mental wellbeing.

The TGA has issued a requirement for new warnings to be provided with the drug montelukast, commonly used to treat asthma and ...